Wang Zhengran, Elkoustaf Rachid, Batiste Columbus, Lahti Debora, Yao Janis F, Funahashi Tadashi
Susan Samueli Integrative Health Institute, University of California, Irvine, Irvine, CA, USA.
Division of Cardiology, University of California, Irvine School of Medicine, Irvine CA, USA.
Am J Prev Cardiol. 2024 Jul 17;19:100708. doi: 10.1016/j.ajpc.2024.100708. eCollection 2024 Sep.
Studies have shown that both home-based cardiac rehabilitation (HBCR) and center-based cardiac rehabilitation (CBCR) exhibit comparable efficacy in reducing mortality during short-term follow-up periods of up to 12 months. However, research on sex- and race-specific outcomes associated with HBCR is limited. This study examines all-cause mortality and hospital readmission among patients referred to HBCR, with stratification by sex and race.
This Kaiser Permanente Southern California (KPSC) retrospective cohort study followed 6,868 patients from HBCR referral until death, disenrollment, or December 31, 2021. There were 3,835 HBCR graduates, 722 non-graduates, and 2,311 non-enrolled patients. Cox models were used to estimate hazard ratios (HR) and 95 % confidence intervals (CI) comparing 1) HBCR graduates vs. non-enrolled, and 2) HBCR graduates vs. non-graduates, stratified by sex and race. Differential outcomes among strata were analyzed using Kaplan-Meier curves.
Among the 6,868 patients referred to HBCR, 4693 (68.3 %) were male, 2,175 (31.7 %) female, 870 (12.7 %) Asian/Pacific Islander, 731 (10.6 %) African American, 1,612 (23.6 %) Hispanic/Latino, and 3,646 non-Hispanic White (53.1 %). Over a mean follow-up period of 2.28 years, HBCR graduates, compared to patients who did not enroll in HBCR, had overall significantly lower risks of all-cause mortality and hospitalization. These results remained significant with stratification by sex and race. Compared to HBCR non-graduates, HBCR graduates overall had significantly lower risks of all-cause mortality and hospitalization. In the same comparison, mortality risk was significantly reduced for male and White patients; risk of hospital readmission was significantly reduced in both sexes, African American, and White patients. Among HBCR graduates, no significant differences in all-cause mortality or hospital readmission were observed across sexes and races.
HBCR participation is associated with reduction of all-cause mortality and hospital readmission rates across sexes and races. Notably, we observed benefits at varying levels of engagement, which suggests that even partial completion of HBCR is associated with risk reduction. Among HBCR graduates, we found similar outcomes across sexes and races, which suggests that the program can be effective among diverse patient groups.
研究表明,家庭心脏康复(HBCR)和中心心脏康复(CBCR)在长达12个月的短期随访期内降低死亡率方面疗效相当。然而,关于HBCR相关的性别和种族特异性结局的研究有限。本研究调查了转诊至HBCR的患者的全因死亡率和再入院情况,并按性别和种族进行分层。
这项南加州凯撒医疗集团(KPSC)的回顾性队列研究跟踪了6868例从转诊至HBCR开始,直至死亡、退出研究或2021年12月31日的患者。其中有3835例HBCR结业患者、722例未结业患者和2311例未参与患者。使用Cox模型估计风险比(HR)和95%置信区间(CI),比较1)HBCR结业患者与未参与患者,以及2)HBCR结业患者与未结业患者,并按性别和种族进行分层。使用Kaplan-Meier曲线分析各层之间的差异结局。
在转诊至HBCR的6868例患者中,4693例(68.3%)为男性,2175例(31.7%)为女性,870例(12.7%)为亚裔/太平洋岛民,731例(10.6%)为非裔美国人,1612例(23.6%)为西班牙裔/拉丁裔,3646例为非西班牙裔白人(53.1%)。在平均2.28年的随访期内,与未参加HBCR的患者相比,HBCR结业患者的全因死亡率和住院风险总体显著更低。按性别和种族分层后,这些结果仍然显著。与HBCR未结业患者相比,HBCR结业患者的全因死亡率和住院风险总体显著更低。在同一比较中,男性和白人患者的死亡风险显著降低;男女、非裔美国人和白人患者的再入院风险均显著降低。在HBCR结业患者中,未观察到性别和种族之间在全因死亡率或再入院方面存在显著差异。
参与HBCR与降低各性别和种族的全因死亡率及再入院率相关。值得注意的是,我们在不同参与程度水平上都观察到了益处,这表明即使部分完成HBCR也与风险降低相关。在HBCR结业患者中,我们发现不同性别和种族的结局相似,这表明该项目在不同患者群体中都可能有效。